Major burns have previously been considered a contraindication to solid organ donation. We present two cases of successful organ donation and transplantation, after Maastricht category III cardiac death in adult patients with non-survivable burns injury. The implications of the outcome of these cases are that major burns should not be considered a contraindication to organ donation, and that cardiac death provides opportunity for patients with non-survivable burns to contribute to the pool of potential organ donors.
Major burns have previously been considered a contraindication to solid organ donation. We present two cases of organ donation resulting in successful transplantation after Maastricht category III cardiac death (DCD) in adult patients with non-survivable burns injury. The implications of the outcome of these cases are that major burns should not be considered a contraindication to organ donation and that DCD provides opportunity for patients with non-survivable burns to contribute to the pool of potential organ donors.
With the advances in transplantation medicine and surgery over the past decades, there has been a significant increase in the number of patients with end-stage organ failure for whom organ transplantation is now a feasible definitive therapeutic option. Despite increasing acceptance of marginal or extended criteria donors, the increase in potential transplant recipients has not been met by increases in the numbers of medically suitable brain-dead potential organ donors. In response to this increased demand for organ procurement, non-heart beating or DCD has recently re-emerged as a method of expanding the potential donor pool 1 . With modern innovations in transplantation, graft outcomes for some DCD organs have improved and may be comparable to those of brain-dead donor (DBD) organs 2, 3 . Advances in intensive care and improvements in DCD practice have made it viable to consider offering organ donation as part of end-of-life management to patients with fatal non-neurological conditions. Extending the DCD potential donor pool to include patients with fatal non-neurological conditions poses challenges and potential risks of ethical conflict, especially in the context of end-of-life care and consent. Despite the aforementioned advances, the magnitude of hypoperfusion and ischaemic injury to organs remains the dominant factor influencing graft outcome in DCD. DCD donors have been categorised (Maastricht categories I-IV) according to whether such potential ischaemic insult is controlled or uncontrolled 4 ( Table 1) .
Major burns have traditionally been considered a contraindication to solid organ donation due to the potential risks of splanchnic ischaemia associated with burns shock 5 and bacteraemia with burn wound manipulation 6, 7 . The limited published literature on organ retrieval in donors with severe burns relates to procurement from brain-dead donors who have died as a result of associated anoxic or traumatic brain injury. The published cases of organ donation from burns patients are predominantly in paediatric DBD donors 8,9 . We discuss the issues of managing adult patients with non-survivable burns injury including the
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CASE PRESENTATIONS Organ donors
Both patients were middle-aged (<67 years) with extensive (90% or greater) total body surface area and full thickness injuries secondary to explosive volatile flash burns. Neither patient had any other traumatic injury. Both patients were rapidly trans-ferred to tertiary burns centres, arriving within two hours of injury. Initial resuscitation was limited to sedation, intubation and ventilation due to imminently threatened airway, and minimal fluid resuscitation (<2 l) prior to specialist burns evaluation and fatal prognostic determination. The patients had continued support subsequently in intensive care to allow appropriate family consultation and palliative care planning. During family discussions regarding endof-life care, the feasibility of organ donation was raised, with both patients having registered intent to donate on the Australian Organ Donor Register. Within determined limitations of treatment, further resuscitation ( Table 2 ) allowed confirmation of medi cal suitability ( Table 3) .
Determination of medical suitability included routine assessment according to the Transplant Society of Australia and New Zealand criteria 10 and further consultation with transplantation specialists. Though both jurisdictions have lung transplantation programs, the evidence for and risk of burn-related acute respiratory distress syndrome was judged to preclude offering lung donation.
The process of donation was conducted in accordance with local state legislation [11] [12] [13] [14] and local DCD policy and procedure 15, 16 . While both patients had registered their intent to donate on the Australian Organ Donor Register, consent was also obtained from the next of kin for interventions and resuscitation undertaken to assess the feasibility of donation and initiation of palliative care, as well as for the organ procurement after death. In both cases authorisation to proceed with DCD was also obtained from the respective state coroner and designated officers prior to the decision to withdraw cardio-respiratory support (WCRS). Following WCRS, the end-of-life wishes of patients and their families were able to be met, and both patients became renal organ donors after death ( Table 4 ).
TRANSPLANT RECIPIENTS Surgical retrieval of kidneys from the donors was uncomplicated, with calculated warm ischaemic time of 16 and 20 minutes. Three cadaveric kidneys were stored on ice using standard university of Wisconsin solution; a single cadaveric kidney was placed on a Lifeport™ (Organ Recovery Systems Chicago, Itasca, IL, uSA) hypothermic machine perfusion organ preservation system 17 prior to transplantation. The recipients had been dialysis-dependent for more than a year. Transplantation was offered on wait list criteria. Cross-matching was moderate to poor with between 3/6 and 6/6 human leukocyte antigen mismatches with the recipients. Cold ischaemic times were long, ranging from 270-930 minutes (mean 612 minutes). Initial severe delayed graft function affected three recipients. Despite these potential adverse factors, the long-term recipient transplantation outcomes were acceptable.
DISCuSSION
Internationally, there are differences in the Maastricht categories that are offered donation after cardiac death. In Australia and New Zealand, DCD is offered to medically suitable Maastricht category III patients. Death in Australian and New Zealand intensive care practice is a managed outcome, with greater than 90% of deaths being preceded by medical consensus to either limit or withdraw lifesustaining support 18 . Medical decisions to withdraw life-sustaining support are based upon the determination of medical futility and rationale that continuation of intervention would be inconsistent with best medical practice. Such deliberation must be independent of considerations of organ donation. The timing of WCRS is rarely an emergency procedure and is often influenced by cultural, religious, secular and medical factors. DCD does directly affect the timing of WCRS, due to the requirements to evaluate the donor, identify potential recipients and the logistics of co-ordinating surgical and theatre resources. For the DBD donor, interventional support to enable donor evaluation and donation feasibility is maintained after declaration of death. However, for DCD donors, interventional support is required antemortem. In certain potential DCD donors, notably those with fatal non-neurological injury or disease, such interventional support may be significant and may require escalation. An example of such a potential DCD donor is the patient with non-survivable burns. The degree of management and intervention may be constrained by legislative and medicolegal determinations regarding the limitations of authorisation of the next of kin or surrogate decisionmaker to consent to certain types of treatment 19 . While there are variations in individual state legislations, the medicolegal constraints commonly revolve around limitations of the next of kin or surrogate decision-maker to be able to consent to, or authorise, only healthcare interventions that would be deemed to be in the patient's interest and/or consistent with the patient's wishes. Legal debate has focused on interpretation of what is deemed to be the patient's interest, with a consensus that such determinations are based not only on medical best interest, but must also take into account an individual's cultural, religious and social values. In the two DCD burns cases presented, the local legal interpretation of the relevant local state legislation was that the next of kin did not have the authority to sanction ante-mortem interventions that were intended solely for the benefit of potential transplant recipients. In both cases, continuation of interventional support was justified on the basis of a primary intent of supporting the end-of-life needs of the family and patient, enabling an opportunity for relatives to attend, appropriate family consultation and palliative care planning. The advanced health directive of the Australian Organ Donor Register declared that the intent to donate registered by both patients also supported the continuation of interventional care to support a secondary outcome of providing opportunity to donate after death. The ethics supporting this approach are based on the principles of autonomy and of double effect. Ethical deliberation informing clinical practice and the medicolegal debate on ante-mortem healthcare, the intervention in the context of palliative care and end-of-life management is centred on a balance of beneficence and non malice 20 . Both medical teams determined slightly different limitations for treatment ( Table 2 ). The appropriateness of a potential inter vention in endoflife care is judged on the perceived benefit and burden to the patient. In this context, while continued ventilation, sedation and fluid resus citation with the intent of supporting the end-of-life needs of family and patient were considered by both teams to be acceptable, more invasive interventions such as external cardiac massage in the event of cardiac arrest or surgical escharotomy in the event of abdominal compartment syndrome or burns-restricted ventilation were not deemed appropriate. In the past, the risk of ischaemic organ injury due to burns shock has been cited as the rationale for considering major burns to be a contraindication to organ donation. Many aspects of major burns patient resuscitation remain controversial, including fluid formulae and fluid type, use of adjuncts such as inotropes, optimal monitoring and clinical endpoints for the determination of efficacy of resuscitation 21 . The use of urine output as a clinical endpoint has been demonstrated to be unreliable as a marker of organ perfusion in burns resuscitation 22 . There is no published literature advising on early resuscitation in non-survivable burns to facilitate organ donation, nor clinical or laboratory indices to determine a donor's suitability in burns.
The pathophysiology of shock and multi-organ failure in burns is complex, mediated initially by direct thermal tissue injury and hypovolaemia, and subsequently dominated by severe immune and cytokinemediated systemic inflammatory response syndrome (SIRS). Though the relevance of specific inflammatory mediators in severe burns is unclear, they are associated with myocardial depression, endothelial dysfunction, acute respiratory distress syndrome, coagulopathy, acute renal failure and multi-organ failure 21 . These complications commonly evolve after 12-24 hours in severe burns. Enhanced cytokine levels are also implicated in adverse transplant recipient and donor graft outcomes. In transplantation, elevated cytokine levels in braindead organ donors have been demonstrated to correlate with worse recipient outcomes post transplantation [23] [24] [25] . Consistently, the levels of serum cytokines including serum G-CSF, IL-6, IL-8, IL-1β, TNF-α and IL10 are significantly increased in severe burns patients 26 , whereas in brain-dead patients the levels are more variable 27 .
The variation in cytokine levels in brain-dead patients may reflect differing mechanisms of cerebral injury, variance in 'catecholamine storm', and differing dynamics of coning and treatment. The mechanism by which specific inflammatory mediators may enhance allograft immunogenicity and rejection is unclear. The use of high-dose steroids in donors has been advocated to attenuate the adverse SIRS antigenic effect on transplant graft outcome 28, 29 . The evidence for the benefit of steroid use is limited 30 . Whether the magnitude of SIRS and cytokine levels associated with severe burns enhances allograft immunogenicity and the risk of rejection beyond that described in brain-dead donors is also uncertain. The early graft dysfunction that affected the majority of recipients in this case series was likely multi-factorial, related to cold ischaemic time, SIRS mediated graft dysfunction, potential organ ischaemia secondary to either burns shock or the DCD process. The administration of steroids would be of low burden and risk to the potential donor. However, it is unknown whether steroids in this donor group would have improved recipient outcome.
Because of the evolving severe systemic inflam matory response syndrome, associated risk of multiorgan failure and potential cytokine-mediated adverse effects on graft and recipient outcome, there is likely to be an optimal time (within 24-36 hours of the injury) for organs to be retrieved from fatal burns donors. Prompt organ retrieval, before significant burn wound colonisation, would also potentially reduce the risk of burn wound manipulation-induced bacteraemia during procurement.
Whether patients with fatal burns and established acute renal failure could be potential organ donors is also unknown. The mortality of burns patients with acute renal failure is high compared to patients without renal failure. However, most burns patients who required acute renal replacement therapy and survive intensive care unit make a good renal recovery and rarely need dialysis after hospital discharge 31, 32 . The use of ex vivo perfusion organ preservation systems such the Lifeport device may extend the opportunity for marginal organ assessment after retrieval.
The number of patients with non-survivable burns who could be potential organ donors has not been studied. The Australian and New Zealand Burns Association Registry identified 54 patients dying in major burns centres in 2009-2010, with 63% of these having a documented medical consensus to either limit or withdraw support prior to death (accessed from anzba.registry@monash.edu. February 2012). Retro spective case review data in the past five years from a single large centre identified 12 nonsurvivable burns injury patients <65 years of age, dying within 48 hours of hospital admission (Rudd, M. Personal communication. 2012). It is likely that these figures may underestimate the potential number of nonsurvivable burns patients, as not all such patients may be transferred to audited specialist burns centres.
CONCLuSION
The re-emergence of DCD practice has extended the opportunity for patients to become organ donors, even in circumstances where the cause of death is not due to neurological injury. The establishment of effective DCD programs, with the ability to undertake rapid donor evaluation and effect co-ordinated management in response to the clinical, ethical and legal challenges, is central to ensuring successful donor and recipient outcomes in such cases. These issues are highlighted in the cases presented of DCD organ donation after non-survivable burns injury. Major burns should not be considered a contraindication to organ donation and via DCD, patients with non-survivable burns can contribute to the pool of potential organ donors.
